FT : Delivery Hero builds 5% stake in UK rival Deliveroo

Delivery Hero builds 5% stake in UK rival Deliveroo
Berlin-based group’s move comes as companies look to capitalise on new sectors and post-lockdowns growth boost

Delivery Hero, the Berlin-based food delivery group, has built a 5 per cent stake in its UK rival Deliveroo.

The move comes at a time of consolidation in the online food delivery industry, as companies jostle for position in new sectors such as groceries and look to capitalise on the growth boost provided by the pandemic’s lockdowns.

Shares in Deliveroo rose almost 6 per cent to 344p, their highest point since the company began trading in London in March.

Delivery Hero, whose stock was flat at €131.50, already owns minority stakes in several other food delivery groups around the world, including Europe’s largest player, Just Eat Takeaway.com, Spain-based Glovo and Latin America’s Rappi.

Delivery Hero competes against Deliveroo in the Middle East through its Talabat brand, and in Hong Kong and Singapore via its Foodpanda unit.

But the two companies do not overlap in Deliveroo’s largest market, after Delivery Hero struck a deal to sell its UK operations, Hungryhouse, to Just Eat in 2016 for about £200m.

The move initially left analysts stumped. “It is hard to say with conviction at this point what Delivery Hero’s intention is,” said Giles Thorne at Jefferies.

Deliveroo declined to comment. Delivery Hero did not immediately respond to a request for comment. Both companies are set to update investors on current trading this week.

Deliveroo’s shares are yet to return to the 390p price at which it launched its initial public offering but the stock is now up by about 15 per cent over the past month following an upgrade to its growth forecasts on July 8.

The dual-class share structure that riled some investors in the run-up to Deliveroo’s IPO means that Will Shu, chief executive, is able to block any takeover attempt over the next three years.

Delivery Hero’s largest investor, Prosus, increased its stake in the company to about 25 per cent in March. Prosus, the investment arm of South Africa’s Naspers, has made significant investments in food delivery businesses, including India’s Swiggy, Finland’s Wolt and the recently launched German grocery app Flink.

WWD : Bernard Arnault Again World’s Richest Man

Bernard Arnault Again World’s Richest Man
The luxury titan is now worth an estimated $199.9 billion, beating out Amazon's Jeff Bezos for the top spot, according to Forbes

BACK ON TOP: Luxury titan Bernard Arnault is again the world’s richest man, according to Forbes. The chairman and chief executive officer of LVMH Moët Hennessy Louis Vuitton bumped Jeff Bezos from the top slot with a net worth of $199.9 billion, topping the Amazon founder and chairman’s $194.9 billion. Tesla founder Elon Musk was in third with a net worth of $185.5 billion.

While Bezos has been busy blasting himself into space via his Blue Origin rocket, Amazon’s shares haven’t been quite as lofty of late, slumping on Friday to $3,344.94 after hitting a one-month high on July 12 of $3,761. LVMH’s shares, meanwhile, have gone in the other direction, and on Friday rose slightly to close at 698.2 euros. The shares have been driven by LVMH’s strong results for the first half, driven by its fashion and leather goods brands Louis Vuitton and Christian Dior and buoyant demand for luxury goods in Asia and the U.S. as well as recovery in Europe. Arnault’s empire encompasses 75 brands ranging from Dom Pérignon Champagne and Cheval Blanc wine to the La Samaritaine and Bon Marché department stores and Bulgari jewelry.

And while Arnault might not be donning a jumpsuit, cowboy boots and a cowboy hat to go into space, he does have a new blue bauble he can call his very own: iconic jeweler Tiffany, which LVMH acquired last year for $15.8 billion and is in the process of buffing up. Clearly the stock market prefers diamonds to star dust.

WWD : Sephora at Kohl’s: The Big Reveal

Sephora at Kohl’s: The Big Reveal
The two powerhouse retailers have unveiled their first shop-in-shop concept, with 70 more to come this month and 200 more by yearend.

In the battle for beauty market share, the opening salvo has been fired.

The first Sephora at Kohl’s, a partnership between the LVMH Moët Hennessy Louis Vuitton-owned beauty behemoth and the midtier department store, opened in a Kohl’s store in Ramsey, N.J., on Friday. Measuring about 2,500 square feet, the shop-in-shop is located front and center in the 85,000-square-foot store, positioned squarely between the two main entrances, one of which now has a prominent Sephora sign above it.

The move has the potential to be transformational for both retailers. Kohl’s gains instant access to about 125 leading prestige beauty brands (and the customers who love them), while Sephora gains scale and a foothold in the off-mall real estate sector, which has been dominated by Ulta Beauty up till now.

“We are at a pivotal moment in beauty,” said Jean-André Rougeot, chief executive officer of Sephora Americas. “We are seeing these large movements of the top players positioning themselves for the gold medal.”

This year alone, Ulta Beauty unveiled a partnership with Target Corp. to bring prestige beauty to that retailer, while, in addition to the Kohl’s partnership, Sephora made a deal with Zalando in Germany and bought Feelunique in the U.K., while leading U.K. e-commerce player The Hut Group acquired Cultbeauty.com last week.

“It is quickly becoming a much smaller group of players that have a legitimate chance of leading this business,” said Rougeot. “With this move, we are positioning ourselves to be the dominant leader in selective beauty for years to come. The market share with Kohl’s is quite large.”

The numbers are indeed big — Kohl’s had 1,162 stores in 49 states at year-end 2020, with an active consumer base of 65 million people in the U.S. But the hitch is that — up until now at least — those shoppers aren’t visiting the store to buy beauty products.

“We can now be a true beauty destination,” said Michelle Gass, CEO of Kohl’s. “We’ve been working on our strategy of pivoting Kohl’s from a department store to a leading omni-retailer serving an active and casual lifestyle. Beauty is a key part of our strategy.

“All of this transformation is coming together,” she continued. “This is a new Kohl’s, more fresh. A modern, relevant experience.”

Under Gass, the retailer has dramatically trimmed its assortment, cutting 25 apparel brands and focusing on names like Nike, Adidas, Champion, Under Armour and Calvin Klein. While the Menomonee Falls, Wisc.-based Kohl’s has dipped its toes into beauty in the past, partnering with the Estée Lauder Cos. Inc. in 2004 for example on a trio of brands exclusive to the retailer, it was never able to gain traction in the category.

“We’ve done some experimentation along the way, but we haven’t ever really been in the beauty business,” said Gass. “The little we did do and the more we put in front of our customer, though, she was voting that she wants beauty at Kohl’s. Our beauty business grew 40 percent-plus over the last few years — and though it was small, it was resonating.”

Gass declined to comment on sales expectations for Sephora at Kohl’s and how beauty is expected to rank versus other key categories, but did say she expects the business to be “significant.”

“You can see the investment we’re making in the business — the store-in-store concept we built, the investment in the digital experience, the investments in marketing,” she said. “We are making a very big bet on beauty, specifically Sephora at Kohl’s.”

If this first outpost is any indication, Kohl’s has put its money where its mouth is.

“They definitely get points for the ‘wow’ factor,” said Jefferies analyst Stephanie Wissink. “It was distinctly and distinctively Sephora — everything you need and a bit more.

“Partnership works when each is allowed to do what they do best and that happened here — Sephora gets to be Sephora and Kohl’s gets to be the host, leveraging its off-mall real estate, customer loyalty and omni-platform,” she continued. “The rest of the store is brand-rich and Kohl’s-curated, but Sephora is figuratively and literally the centerpiece. It’s game on in beauty and Kohl’s brought a ‘pretty powerful’ weapon to the fight.

To that end, Sephora at Kohl’s feels like a stand-alone Sephora store, set apart from the rest of the box with its signature gondolas, signage and black-and-white color scheme, down to the striped floor. Each store will have a team of 15 Kohl’s employees manning the area who have been trained by Sephora. Even the lighting is different from that in the rest of the store.

“Lighting is crucial for the success of beauty,” said Rougeot. “This is top-notch, luxury lighting — not even all of our stores have it. This store checks the box of what our consumers and brands expect.”

As reported, the brand lineup is very robust, with about 125 brands overall and more than 8,500 stock keeping units. The space is evenly divided between skin care on the left and makeup on the right, with hair care and fragrances lining the back walls. The Sephora Collection is housed on a full wall adjacent to makeup, and multibranded Sephora merchandising areas like Beauty on the Go, Clean at Sephora and Top Picks are also featured.

Legacy brands include Estée Lauder, Clinique, Lancôme and Kiehl’s. Buzzy players like Olaplex, Fenty Beauty, Drunk Elephant, Charlotte Tilbury, Milk Makeup, Briogeo, Ilia and The Ordinary are well positioned, while newer names like Gisou in hair care and Patrick Ta’s One Size round out the offering. Fragrance features luxe brands like Tom Ford, Giorgio Armani and YSL, as well as niche players such as Nest Fragrances (the first brand to sign on, said Rougeot) and Juliette Has a Gun. Signage featuring “Clean Beauty Under $20” and “Sephora Collection Under $20” call out the value-driven aspects of the proposition.

Artemis Patrick, executive vice president and global chief merchandising officer of Sephora, noted that she and her team had an amazing reaction from the brands, and that about 90 percent of the offering in a stand-alone Sephora is represented at Kohl’s.

For their part, brands seem equally as bullish on the concept. “This new distribution that completely mirrors the high-quality experience people love at Sephora combined with Kohl’s 60-plus million database, most of whom are incremental to Sephora’s Beauty Insider program, will mean that we have a big awareness and trial opportunity with clients, but also an opportunity to build stronger relationships with existing clients,” said Tim Coolican, CEO of Milk Makeup. “We expect that this is a significant opportunity that could grow our U.S. business by at least an additional 50 percent once Sephora at Kohl’s reaches full distribution.”

Plans call for 70 Sephora-at-Kohl’s to open this month, with 200 total by yearend. That number will reach 800 total within the next few years. The size and speed of Kohl’s was one key reason Sephora chose to partner with it for expansion, rather than go it alone and open more off-mall stores on its own.

“Kohl’s is a bit of a magic wand — doing 200 stores in eight weeks is quite remarkable,” said Rougeot. “We are basically tripling the size of our fleet in two years. That’s something that this partnership allows us to do. We are getting reach, which is very important to us, at a much higher speed and we are getting it with great quality.”

Tapping into Kohl’s real estate strategy is another key advantage for Sephora, particularly vis-à-vis archrival Ulta Beauty, which has about 1,250 stores in all 50 states, primarily in strip malls.

“We are just not very convenient for most of the American population today. To be fair, Ulta has done a phenomenal job of taking advantage of that,” said Rougeot. “They are a more convenient retailer — as of yesterday. Looking forward, it’s a completely different ballgame. Completely different.”

Wissink estimates that there is overlap between Kohl’s and Ulta stores in about 70 percent of locations, and here, in this New Jersey location alone, there is an Ulta Beauty across the street and a Sally Beauty about 10 doors down in the same strip mall.

Rougeot expressed confidence that Sephora’s proposition will win in the end. “Since I came [to Sephora Americas], I’ve talked about reach and being more competitive with Ulta,” he said. “This is a very aggressive drive to offer customers an alternative. I believe strongly that when we fight head-to-head, we win. We have a better assortment, a more interesting story, better service levels.

“Ulta is a great company and I respect them for sure,” said Rougeot, who worked closely with that retailer when he headed up Benefit Cosmetics. “But I think our stores are better and the fact that we can now bring the Sephora experience to pretty much everywhere Ulta is, is a huge win for us.”

Already, online sales, which launched Aug. 1., are trending well. All categories are beating estimates, said Patrick, who noted that hair care and fragrance performing exceptionally well.

“The brands are very comfortable with this — we are already getting great feedback on the dot-com,” said Patrick. “The numbers are significantly better than forecast — well above what we expected. There is strong pent-up demand.”

Moreover, the Kohl’s shopper is not expected to cannibalize Sephora’s existing base. “The power of this partnership is scale,” added Doug Howe, chief merchandising officer of Kohl’s, who noted that 70 percent of the 65 million active customers are women. “And there is very little overlap with the Sephora shopper,” he added.

Rougeot said early indicators from online sales show that this is a consumer who is eager for what’s trending and relevant and new in the category.

“Exclusivity continues to be very important. Beauty is fun. Beauty is play,” he said. “As a consumer, you’re always looking for new.

“Patrick Ta and Charlotte Tilbury are two of the biggest successes on [Sephora at Kohl’s] dot-com thus far. I didn’t necessarily expect that,” Rougeot continued. “But the consumer is smart. The Kohl’s consumer knows exactly what is happening in beauty. She just couldn’t find those brands before, and now they are within her grasp.”

>>> Europe : Brokers Upgrades & Downgrades - 9th of August 2021 V2(+)

>>> Up
* Commerzbank Raised to Buy at Citi
* Hugo Boss Raised to Hold at DZ Bank; PT 53 euros (+)
* Nurminen Logistics Raised to Reduce at Inderes; PT 1.10 euros
* Outokumpu Raised to Add at AlphaValue/Baader
* Pirelli Raised to Neutral at JPMorgan; PT 5.60 euros
* Stellantis Raised to Buy at AlphaValue/Baader
* Tesla Raised to Buy at Jefferies; PT $850

>>> Down
* Bet-at-Home Cut to Hold at FMR Frankfurt Main; PT 32 euros
* CM Cut to Neutral at Kempen & Co; PT 45 euros
* ConvaTec Cut to Underperform at RBC; PT 213 pence
* Daimler Cut to Hold at Jefferies; PT 82 euros
* Galapagos Cut to Hold at Deutsche Bank
* HeidelbergCement Cut to Underweight at Barclays; PT 73 euros
* Hikma Cut to Equal-Weight at Morgan Stanley; PT 2,600 pence
* IG Group Cut to Add at Peel Hunt; PT 1,000 pence
* Iliad Cut to Equal-Weight at Barclays; PT 182 euros
* IMCD Cut to Hold at Berenberg; PT 145 euros
* Kongsberg Cut to Neutral at SpareBank; PT 260 kroner
* Novo Nordisk Cut to Hold at SEB Equities; PT 650 kroner (+)
* Poenina Holding Cut to Market Perform at ZKB (+)
* Raiffeisen Cut to Underperform at KBW; PT 22.50 euros
* Savills Cut to Hold at Peel Hunt; PT 1,210 pence
* Schaltbau Cut to Sell at M.M. Warburg; PT 53.50 euros (+)

>>> Initiation
* Acciona Resumed Buy at Citi; PT 190 euros
* Allianz Tech Rated New Buy at Investec
* ANE SM Rated New Overweight at Morgan Stanley; PT 36 euros
* AstraZeneca Resumed Overweight at Morgan Stanley; PT 9,800 pence
* Corp Acciona Energias Renovables Rated New Buy at Citi
* Corp Acciona Energias Renovables Rated New Neutral at Goldman
* Orion Reinstated Sell at Goldman; PT 26 euros
* Hexicon Rated New Buy at SpareBank; PT 5 kronor
* Qiagen Reinstated Overweight at Morgan Stanley
* Taylor Maritime Investments Rated New Buy at Jefferies
* Tufton Oceanic Assets/The Fund Rated New Buy at Jefferies
* Vifor Pharma Reinstated Neutral at Goldman; PT 129 Swiss francs

>>> Call
* Corp Acciona Energias Renovables Rated New Buy at Berenberg
* EU Real Estate Stocks May Follow U.S. Peers Higher on Breakout
* Tesla Up to Buy on Earnings Momentum, Daimler to Hold: Jefferies

WSJ : Judge Sides With Norwegian Cruise Line in Suit Over Vaccination Proof in F

Judge Sides With Norwegian Cruise Line in Suit Over Vaccination Proof in Florida
Norwegian is set to offer cruises from Florida to the Caribbean starting Aug. 15; company is requiring passengers to be fully vaccinated before boarding

A federal judge has for now sided with Norwegian Cruise Line Holdings Ltd. in its bid to invalidate Florida’s rule that bars businesses from requiring proof of Covid-19 vaccination from their customers.

U.S. District Judge Kathleen Williams in Miami on Sunday granted the cruise operator’s request for a preliminary injunction that prevents the enforcement of the Florida ban on its vessels departing from the state. The company in July sued Florida’s surgeon general, Scott Rivkees, in the U.S. District Court for the Southern District of Florida.

“While litigation is a strategic tool of last resort, our company has fought to do what we believe is right and in the best interest of the welfare of our guests, crew and communities we visit,” said Daniel Farkas, Norwegian’s general counsel.

The Florida Department of Health and the Florida governor’s office didn’t respond to requests for comment.

The decision comes as Norwegian is set to offer cruises from Florida to the Caribbean starting Aug. 15. Florida is a cruise hub that in 2019 accounted for about 60% of cruise embarkations in the U.S., according to the industry group Cruise Lines International Association.

The company is sticking with its policy to require full vaccinations for all crew and passengers, including children, for initial sailings through Oct. 31 after more than a yearlong hiatus and billions of dollars in losses. On Saturday, Norwegian resumed its U.S. cruise from Seattle to Alaska.

Norwegian, in its lawsuit, argued that restricting the flow of information, in this case, vaccine documentation, affects freedom of speech protected by the First Amendment. It also said Florida’s ban disrupts the flow of interstate and international commerce, in violation of a part in the U.S. Constitution that gives Congress the sole authority to regulate interstate commerce.

Judge Williams said in her order that Norwegian is likely to succeed on the merits in showing that the ban puts burdens on interstate commerce, as many of the ports it plans to sail to have vaccination requirements. She also said the company is likely to prevail on its First Amendment claim.

Norwegian “has demonstrated that public health will be jeopardized if it is required to suspend its vaccination requirement,” Judge Williams said. She said Dr. Rivkees didn’t provide evidence showing that the ban is effective in protecting the medical privacy of Florida residents or preventing discrimination against unvaccinated people.

Florida’s ban, made into law in May, is in place as cruise operators have been working to satisfy guidelines set by the Centers for Disease Control and Prevention. Committing to a 95% vaccination rate for crew and passengers is one way for cruise operators to get the green light from the agency, the CDC said.

The Florida attorney general has asked the Supreme Court for an emergency order blocking the CDC’s Covid-19 guidelines for cruise ships, arguing that the damage to the tourism industry outweighs their public-health benefits. The state sued in April to invalidate the guidelines, arguing they exceeded the CDC’s legal authority and were too burdensome for the cruise industry.

The spread of the Delta variant and surge in Covid-19 cases have led to disruptions in travel and leisure. The global cruise industry, derailed last year by Covid outbreaks on ships in the early stages of the pandemic, resumed sailings internationally last summer. Several cases of Covid-19 have been reported on U.S. voyages this summer, even on ships where most passengers were fully vaccinated.

In its complaint, Norwegian said the potential spread of the Delta variant is another driver of its decision to require full Covid-19 vaccinations.

Norwegian saw a slight decrease in net new booking activity in July, Chief Executive Frank Del Rio said on a conference call Friday. The cruise operator views the variant as a temporary phenomenon that isn’t likely to have lasting effects, he said.

WSJ : Chicken Producer Sanderson Farms Nears Sale to Continental Grain, Cargill

Chicken Producer Sanderson Farms Nears Sale to Continental Grain, Cargill
Potential $4.5 billion deal would value poultry giant at $203 a share

Sanderson Farms Inc. SAFM 0.59% is nearing a deal to sell itself for around $4.5 billion, according to people familiar with the matter, as the poultry giant rides a wave of demand for chicken products.

Sanderson is in advanced talks with Cargill Inc. and agricultural-investment firm Continental Grain Co., which owns a smaller chicken processor, the people said. The deal could be finalized by Monday, they said.

It would value Sanderson at $203 a share, about 30% above the price before The Wall Street Journal reported in June that the company had attracted interest from suitors including Continental.

Mississippi-based Sanderson is the country’s third-biggest chicken producer. It runs 13 poultry plants from North Carolina to Texas, processing about 13.6 million chickens a week. The company supplies grocery chains including Walmart Inc. WMT -0.18% and Albertsons ACI 6.09% Cos. as well as restaurant distributors like Sysco Corp. SYY 0.54% and US Foods Holding Corp. USFD 1.58%

Combining Sanderson with Georgia-based Wayne Farms LLC, a poultry company owned by Continental, would form a new competitor representing about 15% of U.S. chicken production, according to data from Watt Poultry USA. Tyson Foods Inc. leads the industry with about one-fifth of the market, while Pilgrim’s Pride Corp. PPC 1.29% represents about 16% of the national total.

These are boom times for the often-cyclical chicken industry. Surging demand for chicken breasts, wings and other products has propelled poultry prices as restaurants reopen and—in the case of the chains like McDonald’s Corp. MCD -0.07% and Shake Shack Inc. SHAK -2.55% —battle to launch crispy chicken sandwiches. Wholesale breast prices are roughly double what they were at the beginning of the year, according to U.S. Department of Agriculture data; wing prices have hit records.

Sanderson’s sales for the quarter ended April 30 climbed by about one-third and its profits jumped to $97 million, versus $6 million during the same period in 2020.

Sanderson got its start in 1947 as a farm-supply store. Joe Sanderson, the founder’s grandson, has been the company’s chief executive since 1989 and chairman since 1998. He owns approximately 3.7% of the company’s shares, according to a regulatory filing.

Wayne Farms was founded in 1895 as a feed-milling company and later expanded into poultry. Continental bought the company in 1981, and in 2015 announced plans for an initial public offering for Wayne, aiming to consolidate smaller private and family-owned chicken companies. Continental shelved the planned IPO after avian influenza outbreaks killed millions of birds, raising costs for U.S. poultry and egg suppliers.

Closely held Cargill, a 156-year-old company with 155,000 employees in 70 countries, is one of the world’s biggest food suppliers. It buys crops, trades sugar and cotton and processes meat, supplying some of the world’s biggest consumer brands and restaurant chains. The Minnesota-based company is a major chicken supplier in Asia and has other poultry operations in Canada, the U.K. and in Latin America.

New York-based Continental invests in food and agriculture companies including giants like Kraft Heinz Co. KHC 0.70% and Burger King parent Restaurant Brands International Inc. QSR -0.42%

FT : Chemicals groups enjoy M&A revival as pandemic winners flourish

Chemicals groups enjoy M&A revival as pandemic winners flourish
Companies sell off businesses to focus on speciality areas such as Covid vaccine ingredients

The chemicals industry has enjoyed a dealmaking renaissance this year as companies step up supplies to businesses that have flourished during the pandemic.

The rapid pace of carve-outs and buyouts has been driven by a desire to concentrate on high-margin, speciality areas such as the manufacture of ingredients to boost immunity in Covid-19 vaccines.

Cheap financing has helped M&A bounce back with $25.1bn worth of deals in the chemicals sector in the first quarter compared with $41.3bn for the whole of 2020, according to Young & Partners.

“The market is healthy and showing clear signs of a pick-up in M&A volume since the first quarter and for the rest of the year,” said Peter Young, chief executive of the New York-based boutique bank.

Kirk McIntosh at investment bank Piper Sandler said: “The M&A market in chemicals is very strong right now. There are a whole series of drivers of that. At a macro level, there’s a huge amount of capital chasing a home.”


A standout example of the carve-out trend was Switzerland-based Lonza Group’s $4.6bn sale of its speciality ingredients business, LSI, to private equity firms Bain Capital and Cinven, allowing the remaining company to focus solely on the booming healthcare industry.

The sale of LSI, a specialist in controlling harmful microbes, fetched a multiple of 13 times earnings, underlining the interest in the hygiene sector because of the pandemic.

Marc Doyle, chief executive of LSI and a former DuPont executive, said: “There is more awareness and sensitisation to the need for cleanliness. Going forward, we view the opportunity to build this sanitisation capability into more consumer products.”

Another example of the trend is Croda’s plan to sell three-quarters of its performance technologies business that does not relate to the supercharged healthcare and beauty markets that the Yorkshire-based speciality chemicals company wants to focus on.

“The strategic decision was based on the competition for capital within Croda,” said Steve Foots, chief executive of the producer of lipids for BioNTech/Pfizer’s messenger RNA Covid vaccine.

Ronald Ayles, managing partner at private equity group Advent International, expects more of these kinds of deals because he thinks many diversified European chemicals companies need to sell more units before reaching a core of exciting, narrowly focused businesses.

“A corporate decides ‘it’s a good quality business but we can’t do it all at the same time’,” he said, after his firm agreed to sell Allnex, an industrial coatings resin producer to Thailand’s PTT Global Chemical for €4bn.

Some of the demands on chemical companies’ resources comes from the need to plough investment into green technology. For example, companies such as BASF, Johnson Matthey and Umicore are racing to become producers of electric car battery materials.

But equally, some bankers also see environmental pressure as an emerging force in sales or separations of CO2-intensive or oil-linked businesses, although that may not be given as the company’s explicit reason.

“You cannot ignore what’s happening around sustainability. It has ramped up in the last 6-12 months,” said Piper Sandler’s McIntosh.

Solvay is carving out its cash-generating soda ash business used in glass and detergents, which accounts for slightly more than 60 per cent of the group’s CO2 emissions, as the Belgian group simplifies its portfolio.

The French group Arkema sold its acrylic business, which relies on petroleum to create the products, to Trinseo in May. Evonik sold a similar business to Advent in 2019.

One notable exception is Ineos, which has been buying up unwanted fossil fuel assets.

However, Alain Harfouche, managing director at investment and advisory financial services group Guggenheim Securities, reckoned such moves were driven more by efforts of reorienting portfolios towards higher-value sectors that tend to be more resilient to commodity cycles or bumps in the global economy and not just by pressure to reduce their carbon footprint.

“It’s very difficult for companies to move away from hydrocarbons [the chief components of petroleum and natural gas],” he said. “It’s consistent with ‘let’s move away from commodities and specialise’. But it’s not a key driver.”

Sustainability is not the only factor complicating M&A. While private equity groups, which have long picked up unloved, capital-starved assets from chemical conglomerates, have made the most of soaring valuations by exiting early, competition to buy has rarely been higher.

“We’ve got a period where both financial buyers and strategics are keen to acquire. There is never enough supply,” said Leland Harrs at US investment bank Houlihan Lokey.

That has pushed valuations painfully high and nowhere more so than in Asia, where about half of M&A deals in the past six years have been completed, data from Young & Partners show.

The merger of Sinochem Group and ChemChina into a titan with $152bn sales represents the sweeping consolidation taking place in China.

“China are not really easy competitors for western industries,” said Bernd Schneider, global co-head of chemicals at US investment bank Stifel.

The bosses of paint companies PPG and Akzo Nobel both said they wanted to buy Asian rivals after the Fortune 500 company beat its Dutch rival to the €1.5bn acquisition of Finland’s Tikkurila in February. But the hot public markets are proving a stiff obstacle.

Akzo’s chief executive Thierry Vanlancker said that “the area where we would be very excited to do things is in Asia. We would love to do more acquisitions but that is the most difficult market to do it because the local markets have very high valuations. Most of the companies want to list with an IPO.”

Michael McGarry, chief executive of Pittsburgh-based PPG, is embarking on an alternative strategy, citing its recent purchase of German industrial coatings group Wörwag. “We’re trying to get those emerging markets by buying US and western European companies with a global presence,” he said.

FT : Distressed debt fund SVP bets Europe will have long ‘hangover’ from Covid

Distressed debt fund SVP bets Europe will have long ‘hangover’ from Covid
Region likely to throw up opportunities for funds focusing on shaky corporate debt, SVP founder says

Europe’s economic and financial “hangover” from the coronavirus crisis will be much longer and more severe than the pain in the US, according to the head of a big US investment group specialising in corporate distress. 

Strategic Value Partners raised a new $5bn fund earlier this week to buy debt issued by struggling companies, with a view to taking them over in a restructuring. The extra funds have catapulted its overall assets under management to $17.5bn.

Previous vintages of the money manager’s “special situations” funds have typically been divided roughly equally between US and Europe, but Victor Khosla, the firm’s founder and chief investment officer, reckons Europe will receive more attention in the coming years. 

“The US is facing a long hangover from Covid, but the hangover that is coming in Europe will be much worse,” he said in an interview. “When we think about what’s coming over the next couple of years, Europe is going to be a bit more centre stage for us than it has been over the past year.”

The aggressive crisis-fighting measures of central banks and governments around the world have helped engineer a powerful market rebound and a strong economic recovery, easing much of the financial strain that typically supports ‘distressed debt’ and ‘special situations’ funds. 

The average yield of US junk bonds — debt issued by companies rated below investment grade — has tumbled from a peak of over 11 per cent in March 2020 to under 4 per cent earlier this summer. That drop, the flip side of rising prices, takes yields to their lowest since at least 1996, according to ICE data. 

Junk bond yields are even lower in Europe, thanks to the European Central Bank’s own aggressive quantitative easing programme and below-zero interest rates. The effective yield of ICE’s euro-denominated “high yield” index is just 2.3 per cent. 

However, the legacy of the Covid crisis will be more indebted companies, which will elongate the distressed debt cycle and make many firms vulnerable to any fresh economic setbacks, Khosla argues. “Europe had a much worse crash than the US, and its recovery is much slower than the US,” he said. 

And in Europe, dud corporate loans are clogging up the books of big commercial banks, with some of the debt dating back to the eurozone crisis a decade ago. The ECB warned last year that in a “severe but plausible” scenario, non-performing loans in the continent could reach €1.4tn. 

Although that now looks less likely with the economic rebound gathering pace, Andrea Enria, the ECB’s main bank supervisor, warned in a speech last month that giving European banks too much leeway in dealing with these bad debts “would mean accepting that the EU banking sector may remain clogged with pandemic-related secured NPLs for longer than a decade, leaving it unprepared to face the next recession”.

Khosla stressed that SVP’s decision to raise the new $5bn fund did not indicate that the group expected an economic crash any time soon, and argued that the scale of central bank support likely meant that financial markets would remain buoyant for the foreseeable future. 

“We are not boom-and-bust based investors. If there is a big crash we can accelerate our investments, but we aim to invest steadily,” he said. “Markets are strong at the moment, and we don’t think they’re going to collapse over the next year or two.” 

SVP’s four earlier special situations funds produced a net return of 15 per cent a year, according to a presentation by the Connecticut Retirement Plans and Trust Funds, a state pension fund, which invested in the fifth one. 

FT : Renault targets China electric vehicle market with Geely tie-up

Renault targets China electric vehicle market with Geely tie-up
French group signs first big deal in country since exiting joint venture last year


Please use the sharing tools found via the share button at the top or side of articles. Copying articles to share with others is a breach of FT.com T&Cs and Copyright Policy. Email licensing@ft.com to buy additional rights. Subscribers may share up to 10 or 20 articles per month using the gift article service. More information can be found at https://www.ft.com/tour.

Renault will partner with Geely to sell hybrid cars in China, marking the French group’s first big deal in the world’s second-biggest economy since it exited its main joint venture last year.

Geely, the Chinese owner of Sweden’s Volvo Cars, and Renault said on Monday they would share resources and technology to sell hybrid vehicles in Asia in an effort by the latter to tap into China’s rapidly growing electric car market.

Renault pulled out of a lossmaking petrol car joint venture with China’s Dongfeng Motor Group in April 2020 after the coronavirus pandemic deepened two years of declining sales. The withdrawal was a rare example of an international automaker reducing its presence in the world’s largest car market.

It was also a reversal of a strategy put in place in 2016 by Carlos Ghosn, the former Renault chief. The company had retained a small presence in China through its light commercial vehicle business with Brilliance China and an electric car joint venture with Jiangling Motors.

The French group and Geely will make Renault-branded hybrids, with the former focusing on branding and customer service. The companies will also partner in South Korea, where Renault has a tie-up with Samsung. The two groups plan to make cars based on platforms from Lynk & Co, a hybrid-focused brand founded by Geely in 2016.

Geely, which also has a minority stake in Germany’s Daimler and is China’s largest privately owned automaker by vehicles sold, has been moving to position itself at the core of the global automobile industry’s switch towards EVs.

In the past year, Geely has opened up its electric car manufacturing architecture to partners, including the internet group Baidu, and has launched a premium electric car brand to try and take on industry leader Tesla.

Sales of so-called new energy vehicles, which include battery-powered and plug-in hybrids, have accelerated rapidly in China since mid-2020 following a year-long decline after the government cut subsidies.

The success of Tesla and local EV makers such as Nio, Li Auto and Xpeng has led to fierce competition in the sector and pressured global automakers to launch electrified models that appeal to Chinese consumers.

After more than three years of hovering at 5 per cent of total car sales, China’s new energy vehicles market rose to about 10 per cent of sales in the first half of 2021. Beijing wants these vehicles to account for about 20 per cent of total car sales by 2025.

FT : Philip Morris raises Vectura bid to more than £1bn

Philip Morris raises Vectura bid to more than £1bn
China’s tech tycoons lose $87bn, Latvia warns of Nato-Russia ‘incident’, Messi bids farewell to Barcelona

The battle between Philip Morris International and a private equity group for control of the UK inhaler maker Vectura intensified yesterday as the Marlboro maker raised its bid to more than £1bn.

PMI made its offer of 165p a share just two days after Carlyle, the US private equity group, raised its own bid for Wiltshire-based Vectura to 155p a share.

That offer won the backing of Vectura’s board and a group of investors that owns 11.2 per cent of Vectura’s equity, including Axa Investment Managers. The PMI offer values Vectura’s equity at £1.02bn, compared with Carlyle’s £928m.

The Vectura bid battle comes as private equity launches its largest raid on listed UK businesses in decades, taking advantage of depressed valuations in the wake of Brexit and the pandemic.